NO20054085L - Substituerte heksahydropyrazino [1,2-a]pyrimidin-4,7-dionderivater, fremgangsmater for fremstilling og anvendelse derav som medikamenter - Google Patents

Substituerte heksahydropyrazino [1,2-a]pyrimidin-4,7-dionderivater, fremgangsmater for fremstilling og anvendelse derav som medikamenter

Info

Publication number: NO20054085L
Authority: NO; Norway
Prior art keywords: pyrimidine; preparation; medicaments; methods; dione derivatives
Prior art date: 2003-02-13

Application number

NO20054085A

Other languages

English (en)

Norwegian (no)

Inventor

Matthias Gossel

Thomas Klabunde

Siegfried Stengelin

Stefanie Flohr

Original Assignee

Aventis Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-02-13

Filing date

2005-09-02

Publication date

2005-09-02

2003-02-13 Priority claimed from DE10305885A external-priority patent/DE10305885A1/de

2003-10-24 Priority claimed from DE10349672A external-priority patent/DE10349672A1/de

2005-09-02 Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh

2005-09-02 Publication of NO20054085L publication Critical patent/NO20054085L/no

Links

CYCRMTFRHLQFIV-UHFFFAOYSA-N 2,3,6,8,9,9a-hexahydro-1h-pyrazino[1,2-a]pyrimidine-4,7-dione Chemical class N1CCC(=O)N2C1CNC(=O)C2 CYCRMTFRHLQFIV-UHFFFAOYSA-N 0.000 title abstract 2
239000003814 drug Substances 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
229940125709 anorectic agent Drugs 0.000 abstract 1
239000002830 appetite depressant Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Diabetes (AREA)
Dermatology (AREA)
Obesity (AREA)
Hematology (AREA)
Psychiatry (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Heart & Thoracic Surgery (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Hospice & Palliative Care (AREA)
Emergency Medicine (AREA)
Vascular Medicine (AREA)
Addiction (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Anesthesiology (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Urology & Nephrology (AREA)
Child & Adolescent Psychology (AREA)

NO20054085A 2003-02-13 2005-09-02 Substituerte heksahydropyrazino [1,2-a]pyrimidin-4,7-dionderivater, fremgangsmater for fremstilling og anvendelse derav som medikamenter NO20054085L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE10305885A DE10305885A1 (de)	2003-02-13	2003-02-13	Substituierte Hexahydro-pyrazino(1,2-a)pyrimidin-4,7-dionderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10349672A DE10349672A1 (de)	2003-10-24	2003-10-24	Substituierte Hexahydro-pyrazino(1,2-a)pyrimidin-4,7-dionderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
PCT/EP2004/000769 WO2004072076A1 (de)	2003-02-13	2004-01-29	Substituierte hexahydro-pyrazino(1,2-a)pyrimidin-4,7-dionderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (1)

Publication Number	Publication Date
NO20054085L true NO20054085L (no)	2005-09-02

Family

ID=32870334

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20054085A NO20054085L (no)	2003-02-13	2005-09-02	Substituerte heksahydropyrazino [1,2-a]pyrimidin-4,7-dionderivater, fremgangsmater for fremstilling og anvendelse derav som medikamenter

Country Status (21)

Country	Link
EP (1)	EP1599480B1 (pl)
JP (1)	JP2006517550A (pl)
KR (1)	KR20050111588A (pl)
AR (1)	AR043155A1 (pl)
AT (1)	ATE472548T1 (pl)
AU (1)	AU2004212042A1 (pl)
BR (1)	BRPI0407507A (pl)
CA (1)	CA2515735A1 (pl)
CO (1)	CO5690597A2 (pl)
DE (1)	DE502004011328D1 (pl)
HR (1)	HRP20050712A2 (pl)
MA (1)	MA27654A1 (pl)
MX (1)	MXPA05007516A (pl)
MY (1)	MY135902A (pl)
NO (1)	NO20054085L (pl)
PE (1)	PE20050192A1 (pl)
PL (1)	PL377227A1 (pl)
RS (1)	RS20050564A (pl)
RU (1)	RU2005128497A (pl)
TW (1)	TW200508235A (pl)
WO (1)	WO2004072076A1 (pl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8080657B2 (en)	2001-10-12	2011-12-20	Choongwae Pharma Corporation	Compounds of reverse turn mimetics and the use thereof
US20040072831A1 (en) *	2001-10-12	2004-04-15	Choongwae Pharma Corporation	Reverse-turn mimetics and method relating thereto
US7671054B1 (en)	2001-10-12	2010-03-02	Choongwae Pharma Corporation	Reverse-turn mimetics and method relating thereto
US7576084B2 (en)	2001-10-12	2009-08-18	Choongwae Pharma Corporation	Reverse-turn mimetics and method relating thereto
US7566711B2 (en)	2001-10-12	2009-07-28	Choongwae Pharma Corporation	Reverse-turn mimetics and method relating thereto
US7232822B2 (en)	2001-10-12	2007-06-19	Choongwae Pharma Corporation	Reverse-turn mimetics and method relating thereto
CA2514791A1 (en) *	2003-02-13	2004-08-26	Aventis Pharma Deutschland Gmbh	Nitrogen-substituted hexahydropyrazino[1,2-a]pyrimidine-4,7-dione derivatives, method for the production and use thereof as medicaments
DE102004042441A1 (de) *	2004-08-31	2006-04-06	Sanofi-Aventis Deutschland Gmbh	Mit Aminosäuren substituierte Hexahydro-pyrazino(1,2-a)pyrimidin-4,7-dionderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP2308840A1 (en)	2005-06-30	2011-04-13	Prosidion Limited	GPCR agonists
WO2007056513A1 (en) *	2005-11-08	2007-05-18	Institute For Chemical Genomics	α-HELIX MIMETICS AND METHODS RELATING TO THE TREATMENT OF FIBROTIC DISORDERS
WO2007056593A2 (en) *	2005-11-08	2007-05-18	Choongwae Pharma Corporation	α-HELIX MIMETICS AND METHOD RELATING TO THE TREATMENT OF CANCER STEM CELLS
AU2007283113A1 (en)	2006-08-08	2008-02-14	Sanofi-Aventis	Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use
GB0700122D0 (en)	2007-01-04	2007-02-14	Prosidion Ltd	GPCR agonists
AR064735A1 (es)	2007-01-04	2009-04-22	Prosidion Ltd	Agonistas de gpcr y composicion farmaceutica en base al compuesto
ES2373181T3 (es)	2007-01-04	2012-02-01	Prosidion Ltd	Agonistas de gpcr de piperidina.
EP2114936A1 (en)	2007-01-04	2009-11-11	Prosidion Limited	Piperidine gpcr agonists
PE20081849A1 (es)	2007-01-04	2009-01-26	Prosidion Ltd	Derivados de piperidin-4-il-propoxi-benzamida como agonistas de gpcr
EP2025674A1 (de)	2007-08-15	2009-02-18	sanofi-aventis	Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
GB0720389D0 (en)	2007-10-18	2008-11-12	Prosidion Ltd	G-Protein Coupled Receptor Agonists
GB0720390D0 (en)	2007-10-18	2007-11-28	Prosidion Ltd	G-Protein coupled receptor agonists
UY31968A (es)	2008-07-09	2010-01-29	Sanofi Aventis	Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos
WO2010068601A1 (en)	2008-12-08	2010-06-17	Sanofi-Aventis	A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
KR20120060207A (ko)	2009-08-26	2012-06-11	사노피	신규한 결정성 헤테로방향족 플루오로글리코시드 수화물, 이들 화합물을 포함하는 약제 및 이들의 용도
US8710050B2 (en)	2011-03-08	2014-04-29	Sanofi	Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2683702B1 (de)	2011-03-08	2014-12-24	Sanofi	Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
US8871758B2 (en)	2011-03-08	2014-10-28	Sanofi	Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
US8809325B2 (en)	2011-03-08	2014-08-19	Sanofi	Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof
WO2012120058A1 (de)	2011-03-08	2012-09-13	Sanofi	Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2683704B1 (de)	2011-03-08	2014-12-17	Sanofi	Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8828994B2 (en)	2011-03-08	2014-09-09	Sanofi	Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2683703B1 (de)	2011-03-08	2015-05-27	Sanofi	Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2766349B1 (de)	2011-03-08	2016-06-01	Sanofi	Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
CN121002044A (zh) *	2023-04-21	2025-11-21	香港大学	作为抗糖尿病药物的新型胰岛素受体(insr)小分子激动剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6184223B1 (en) *	1995-10-27	2001-02-06	Molecumetics Ltd.	Reverse-turn mimetics and methods relating thereto
DE69837264T2 (de) *	1997-06-25	2008-01-31	Pfizer Inc.	Dipeptidverbindungen, die Wachstumshormon-Sekretagoga sind
US6294525B1 (en) *	1999-09-01	2001-09-25	Molecumetics Ltd.	Reverse-turn mimetics and methods relating thereto
CA2514791A1 (en) *	2003-02-13	2004-08-26	Aventis Pharma Deutschland Gmbh	Nitrogen-substituted hexahydropyrazino[1,2-a]pyrimidine-4,7-dione derivatives, method for the production and use thereof as medicaments

2004
- 2004-01-29 KR KR1020057014859A patent/KR20050111588A/ko not_active Withdrawn
- 2004-01-29 AU AU2004212042A patent/AU2004212042A1/en not_active Abandoned
- 2004-01-29 PL PL377227A patent/PL377227A1/pl not_active Application Discontinuation
- 2004-01-29 BR BRPI0407507-2A patent/BRPI0407507A/pt not_active IP Right Cessation
- 2004-01-29 DE DE502004011328T patent/DE502004011328D1/de not_active Expired - Lifetime
- 2004-01-29 CA CA002515735A patent/CA2515735A1/en not_active Abandoned
- 2004-01-29 EP EP04706170A patent/EP1599480B1/de not_active Expired - Lifetime
- 2004-01-29 RU RU2005128497/04A patent/RU2005128497A/ru not_active Application Discontinuation
- 2004-01-29 AT AT04706170T patent/ATE472548T1/de not_active IP Right Cessation
- 2004-01-29 HR HR20050712A patent/HRP20050712A2/xx not_active Application Discontinuation
- 2004-01-29 MX MXPA05007516A patent/MXPA05007516A/es not_active Application Discontinuation
- 2004-01-29 RS YUP-2005/0564A patent/RS20050564A/sr unknown
- 2004-01-29 JP JP2006501649A patent/JP2006517550A/ja active Pending
- 2004-01-29 WO PCT/EP2004/000769 patent/WO2004072076A1/de not_active Ceased
- 2004-02-09 PE PE2004000147A patent/PE20050192A1/es not_active Application Discontinuation
- 2004-02-11 AR ARP040100427A patent/AR043155A1/es unknown
- 2004-02-11 TW TW093103121A patent/TW200508235A/zh unknown
- 2004-02-12 MY MYPI20040456A patent/MY135902A/en unknown
2005
- 2005-08-11 CO CO05079789A patent/CO5690597A2/es not_active Application Discontinuation
- 2005-08-11 MA MA28428A patent/MA27654A1/fr unknown
- 2005-09-02 NO NO20054085A patent/NO20054085L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
PE20050192A1 (es)	2005-04-01
RS20050564A (sr)	2007-09-21
CO5690597A2 (es)	2006-10-31
AU2004212042A1 (en)	2004-08-26
KR20050111588A (ko)	2005-11-25
EP1599480B1 (de)	2010-06-30
DE502004011328D1 (de)	2010-08-12
HRP20050712A2 (en)	2006-09-30
WO2004072076A1 (de)	2004-08-26
BRPI0407507A (pt)	2006-02-14
EP1599480A1 (de)	2005-11-30
ATE472548T1 (de)	2010-07-15
CA2515735A1 (en)	2004-08-26
TW200508235A (en)	2005-03-01
AR043155A1 (es)	2005-07-20
PL377227A1 (pl)	2006-01-23
MA27654A1 (fr)	2005-12-01
JP2006517550A (ja)	2006-07-27
RU2005128497A (ru)	2006-01-27
MY135902A (en)	2008-07-31
MXPA05007516A (es)	2006-01-27

Legal Events

Date	Code	Title	Description
2009-08-31	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20054085L (no)	2005-09-02	Substituerte heksahydropyrazino [1,2-a]pyrimidin-4,7-dionderivater, fremgangsmater for fremstilling og anvendelse derav som medikamenter
NO20054208L (no)	2005-09-09	Nitrogen-substituerte heksahydropyrazino[1,2-a]pyrimidin-4,7-dionderivater, fremgangsmater for fremstilling og anvendelse derav som medikamenter
TNSN05194A1 (en)	2007-06-11	Substituted n-arylheterocycles, method for production and use thereof as medicaments
MX337817B (es)	2011-11-04	Pirazolo [1,5-a] pirimidinas de utilidad como inhibidores de proteina quinasas.
MX2010006748A (es)	2010-08-18	Pirazolo[1,5-a]pirimidinas utiles como inhibidores de jak2.
TW200606162A (en)	2006-02-16	Pyrazolopyridine derivatives
NO20054905L (no)	2006-01-25	2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika
ES2195785A1 (es)	2003-12-01	Nuevos derivados de piridazin-3(2h)-ona.
GEP20084551B (en)	2008-11-25	4-phenylamino-quinazolin-6-yl-amides
BRPI0510560A (pt)	2007-11-20	pirido[2,3-d] pirimidin-7-onas pirrolil substituìdas e seus derivados como agentes terapêuticos
NO20055649L (no)	2006-01-31	Substituert dihydrokinazolin med antiviale egenskaper
TW200613305A (en)	2006-05-01	Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one
NO20072089L (no)	2007-06-15	Benzimidazolderivater, sammensetninger som inneholder dem, fremstilling derav og anvendelse derav
CY1109366T1 (el)	2014-07-02	Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
MY140630A (en)	2010-01-15	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
WO2004087700A8 (fr)	2004-11-18	Derives du benzenesulfonamide, leur procede de preparation et leur utilisation de la douleur
MXPA05013050A (es)	2006-03-02	Derivados de bencimidazol, composiciones que los contienen preparacion de los mismos y usos de los mismos.
NO20053809L (no)	2005-10-17	Diarylmetylindenpiperidinderivater,fremgangsmate for fremstilling derav, og anvendelse derav
PT1869038E (pt)	2009-10-06	Compostos de 5,6,7,8-tetra-hidro-imidazo[1,2-a]piridin-2- ilamina substituída e sua utilização para produzir fármacos
BRPI0513287A (pt)	2008-05-06	derivados de pirido-pirimidina, sua preparação, sua aplicação em terapêutica
TW200510399A (en)	2005-03-16	1, 3-substituted cycloalkyl derivatives having acidic, mostly heterocyclic groups; processes for their preparation and their use as pharmaceuticals
NO20063619L (no)	2006-10-09	Diarylmetylpiperazinderivater, fremstilling og anvendelse derav
NO20053805L (no)	2005-10-17	Diarylmetylindenpiperidinderivater, framgangsmate for fremstilling derav, og anvendelse derav
SG146685A1 (en)	2008-10-30	Dihydroporphine derivatives, processes for their preparation, and pharmaceutical compositions containing them
NO20053876L (no)	2005-10-12	Karbonylaminosubstituerte acylfenylurederivater, fremgangsmate for deres fremstilling samt anvendelse derav